Generic name: naldemedine tosylate 0.2mg
Dosage form: tablet
Drug class: Peripheral opioid receptor antagonists
Medically reviewed by Drugs.com. Last updated on Dec 23, 2022.
- Alteration of analgesic dosing regimen prior to initiating SYMPROIC is not required.
- Patients receiving opioids for less than 4 weeks may be less responsive to SYMPROIC [see Clinical Studies (14)].
- Discontinue SYMPROIC if treatment with the opioid pain medication is also discontinued.
Frequently asked questions
More about Symproic (naldemedine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: peripheral opioid receptor antagonists
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.